oligonucleotide (Genta)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameoligonucleotide (Genta)
Drug Alias Nameoligonucleotide (Genta)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionInterleukin-1 modulators
TargetsInterleukin-1
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenta Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenta Incorporated
Active IndicationsN/A
Inactive IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Other Information

ATC CodeN/A
Related LinksN/A